Medical Transcription Billing, Corp. (MTBC) Upgraded to “Hold” by Zacks Investment Research

Medical Transcription Billing, Corp. (NASDAQ:MTBC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, July 19th.

According to Zacks, “Medical Transcription Billing, Corp. is a healthcare information technology company. It engages in providing integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company offers revenue cycle, practice management services, patient scheduling, automated appointment reminders, e-prescribing, lab connectivity, and real-time insurance eligibility verification. Transcription Billing, Corp. is headquartered in Somerset, New Jersey. “

Several other research firms have also recently weighed in on MTBC. Chardan Capital boosted their price target on Medical Transcription Billing, Corp. from $1.85 to $2.25 and gave the stock a “buy” rating in a research note on Monday, May 15th. ValuEngine upgraded Medical Transcription Billing, Corp. from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd.

Shares of Medical Transcription Billing, Corp. (NASDAQ MTBC) opened at 1.4501 on Wednesday. The company has a 50 day moving average of $1.40 and a 200-day moving average of $1.17. The firm’s market capitalization is $14.75 million. Medical Transcription Billing, Corp. has a 12 month low of $0.29 and a 12 month high of $3.84.

Medical Transcription Billing, Corp. (NASDAQ:MTBC) last posted its quarterly earnings results on Thursday, August 3rd. The technology company reported ($0.02) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.17) by $0.15. Medical Transcription Billing, Corp. had a negative return on equity of 59.52% and a negative net margin of 32.88%. The firm had revenue of $7.79 million during the quarter. Analysts predict that Medical Transcription Billing, Corp. will post ($0.69) EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Medical Transcription Billing, Corp. (MTBC) Upgraded to “Hold” by Zacks Investment Research” was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://stocknewstimes.com/2017/08/09/medical-transcription-billing-corp-mtbc-upgraded-at-zacks-investment-research-updated-updated.html.

Medical Transcription Billing, Corp. Company Profile

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Get a free copy of the Zacks research report on Medical Transcription Billing, Corp. (MTBC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Medical Transcription Billing Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply